News
Long-term success demands constant refinement. Here's how to ensure your products and services meet fast-changing ...
MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update Continued to make ...
Phase 2 APEX trial of APG777 in atopic dermatitis advancing with interim Part A 16-week data expected in mid-2025 and Part B actively enrolling First patient dosed in Phase 1b trial of APG777 in ...
Skip the generic mugs and show your appreciation with a gift picked just for her: Whether it's something to make a part of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results